These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8116500)
1. Treatment of calf pneumonia with tilmicosin. Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500 [TBL] [Abstract][Full Text] [Related]
2. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica. Gourlay RN; Thomas LH; Wyld SG; Smith CJ Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410 [TBL] [Abstract][Full Text] [Related]
3. Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin. Morck DW; Merrill JK; Gard MS; Olson ME; Nation PN Can J Vet Res; 1997 Jul; 61(3):187-92. PubMed ID: 9242998 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs. Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749 [TBL] [Abstract][Full Text] [Related]
5. Efficacy evaluations of the use of oral tilmicosin in pneumonic calves. Fodor L; Reeve-Johnson L; Hodge A; Varga J Vet J; 2000 Mar; 159(2):194-200. PubMed ID: 10712808 [TBL] [Abstract][Full Text] [Related]
6. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease. McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206 [TBL] [Abstract][Full Text] [Related]
7. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves. Musser J; Mechor GD; Gröhn YT; Dubovi EJ; Shin S J Am Vet Med Assoc; 1996 Jan; 208(1):102-6. PubMed ID: 8682696 [TBL] [Abstract][Full Text] [Related]
8. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. Moore GM; Basson RP; Tonkinson LV Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813 [TBL] [Abstract][Full Text] [Related]
9. Dose determination and confirmation for ceftiofur crystalline-free acid administered in the posterior aspect of the ear for control and treatment of bovine respiratory disease. Hibbard B; Robb EJ; Chester ST; Dame KJ; Moseley WW; Bryson WL Vet Ther; 2002; 3(1):22-30. PubMed ID: 12050825 [TBL] [Abstract][Full Text] [Related]
10. Efficacy evaluation of the use of oral tilmicosin in pneumonic calves. Huwyler U; Reeve-Johnson L; Korfitsen J; Liesegang A; Wanner M Schweiz Arch Tierheilkd; 1999; 141(4):203-8. PubMed ID: 10228400 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Skogerboe TL; Rooney KA; Nutsch RG; Weigel DJ; Gajewski K; Kilgore WR Vet Ther; 2005; 6(2):180-96. PubMed ID: 16094565 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Nutsch RG; Skogerboe TL; Rooney KA; Weigel DJ; Gajewski K; Lechtenberg KF Vet Ther; 2005; 6(2):167-79. PubMed ID: 16094564 [TBL] [Abstract][Full Text] [Related]
13. Effects of tilmicosin treatment on Pasteurella haemolytica organisms in nasal secretion specimens of calves with respiratory tract disease. Frank GH; Briggs RE; Loan RW; Purdy CW; Zehr ES Am J Vet Res; 2000 May; 61(5):525-9. PubMed ID: 10803647 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves. Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL Vet Ther; 2005; 6(2):143-53. PubMed ID: 16094562 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. Godinho KS; Wolf RM; Sherington J; Rowan TG; Sunderland SJ; Evans NA Vet Ther; 2005; 6(2):122-35. PubMed ID: 16094560 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic efficacy of tilmicosin for bovine respiratory tract disease. Morck DW; Merrill JK; Thorlakson BE; Olson ME; Tonkinson LV; Costerton JW J Am Vet Med Assoc; 1993 Jan; 202(2):273-7. PubMed ID: 8428833 [TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease. Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL Vet Ther; 2005; 6(2):136-42. PubMed ID: 16094561 [TBL] [Abstract][Full Text] [Related]
18. The effects of danofloxacin and tilmicosin on neutrophil function and lung consolidation in beef heifer calves with induced Pasteurella (Mannheimia) haemolytica pneumonia. Fajt VR; Apley MD; Roth JA; Frank DE; Brogden KA; Skogerboe TL; Shostrom VK; Chin YL J Vet Pharmacol Ther; 2003 Jun; 26(3):173-9. PubMed ID: 12755900 [TBL] [Abstract][Full Text] [Related]
19. Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases. Lakritz J; Tyler JW; Marsh AE; Romesburg-Cockrell M; Smith K; Holle JM Vet Ther; 2002; 3(1):7-21. PubMed ID: 12050824 [TBL] [Abstract][Full Text] [Related]
20. Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle. Vogel GJ; Laudert SB; Zimmermann A; Guthrie CA; Mechor GD; Moore GM J Am Vet Med Assoc; 1998 Jun; 212(12):1919-24. PubMed ID: 9638194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]